Neogen Corporation Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2026-02-28 was $700.00K, a 30.00% decline year-over-year.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2025-08-31 was $900.00K, a 10.00% decline year-over-year.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2025-02-28 was $1.00M, a 18.23% decline year-over-year.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for the quarter ending 2024-08-31 was $1.00M, a 3.75% decline year-over-year.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for fiscal 2026 was $1.70M, a 19.05% decline from fiscal 2025.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for fiscal 2025 was $2.10M, a 8.70% decline from fiscal 2024.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.30M, a 23.79% increase from fiscal 2023.
- Neogen Corporation stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.86M, a 0.96% decline from fiscal 2022.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-05-31 | $1.70M 10-K · filed 2026-07-30 | |
| 2026-02-28 | $700.00K 10-Q · filed 2026-04-09 | |
| 2025-08-31 | $900.00K 10-Q · filed 2026-04-09 | |
| 2025-05-31 | $2.10M 10-K · filed 2026-07-30 | |
| 2025-02-28 | $1.00M 10-Q · filed 2026-04-09 | |
| 2024-08-31 | $1.00M 10-Q · filed 2026-04-09 | |
| 2024-05-31 | $2.30M 10-K · filed 2026-07-30 | |
| 2024-02-29 | $1.22M 10-Q · filed 2025-04-09 | |
| 2023-08-31 | $1.04M 10-Q · filed 2025-04-09 | |
| 2023-05-31 | $1.86M 10-K · filed 2025-07-30 | |
| 2023-02-28 | $991.00K 10-Q · filed 2024-04-09 | |
| 2022-08-31 | $867.00K 10-Q · filed 2024-04-09 | |
| 2022-05-31 | $1.88M 10-K · filed 2024-07-30 | |
| 2022-02-28 | $977.00K 10-Q · filed 2023-04-04 | |
| 2021-08-31 | $899.00K 10-Q · filed 2023-04-04 | |
| 2021-05-31 | $1.39M 10-K · filed 2023-08-15 | |
| 2021-02-28 | $720.00K 10-Q · filed 2022-04-01 | |
| 2020-08-31 | $668.00K 10-Q · filed 2022-04-01 | |
| 2020-05-31 | $1.19M 10-K · filed 2022-07-27 | |
| 2020-02-29 | $607.00K 10-Q · filed 2021-03-31 | |
| 2019-08-31 | $538.00K 10-Q · filed 2021-03-31 | |
| 2019-05-31 | $1.16M 10-K · filed 2021-07-30 | |
| 2019-02-28 | $641.00K 10-Q · filed 2020-04-03 | $1.16M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $1.09M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-08-31 | $519.00K 10-Q · filed 2020-04-03 | $1.09M derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-05-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $1.05M 10-K · filed 2020-07-30 |
| 2018-02-28 | $566.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | $1.05M derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $982.00K derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-08-31 | $485.00K 10-Q · filed 2017-09-29 | $982.00K derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | $925.00K 10-K · filed 2019-07-30 |
| 2017-02-28 | $497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | $925.00K derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $854.00K derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-08-31 | $428.00K 10-Q · filed 2016-09-30 | $854.00K derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $786.00K 10-K · filed 2018-07-27 |
| 2016-02-29 | $426.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | $786.00K derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $760.00K derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-08-31 | $360.00K 10-Q · filed 2015-09-30 | $760.00K derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $724.00K 10-K · filed 2017-07-28 |
| 2015-02-28 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $724.00K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $657.00K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-08-31 | $324.00K 10-Q · filed 2014-09-30 | $657.00K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $616.00K 10-K · filed 2016-07-29 |
| 2014-02-28 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $616.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $562.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | $283.00K 10-Q · filed 2013-09-30 | $562.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $536.00K 10-K · filed 2015-07-30 |
| 2013-02-28 | $279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $561.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $544.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | $257.00K 10-Q · filed 2012-09-28 | $544.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $509.00K 10-K · filed 2014-07-30 |
| 2012-02-29 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | |
| 2011-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | |
| 2011-08-31 | $222.00K 10-Q · filed 2011-09-30 | |
| 2011-05-31 | $418.00K 10-K · filed 2013-07-30 | |
| 2010-05-31 | $332.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |